Gevo (GEVO) : Zacks Investment Research ranks Gevo (GEVO) as 3, which is a Hold recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 2 research analysts is 2, which indicates as a Buy.
Gevo (GEVO) : The most positive equity analysts on Gevo (GEVO) expects the shares to touch $5, whereas, the least positive believes that the stock will trade at $1 in the short term. The company is covered by 2 Wall Street Brokerage Firms. The average price target for shares are $3 with an expected fluctuation of $2.83 from the mean.
Company shares have received an average consensus rating of Hold for the current week
Gevo (NASDAQ:GEVO): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $0.54 and $0.53 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $0.67. The buying momentum continued till the end and the stock did not give up its gains. It closed at $0.66, notching a gain of 23.06% for the day. The total traded volume was 18,934,242 . The stock had closed at $0.53 on the previous day.
Gevo, Inc. (Gevo) is a renewable chemicals and biofuels company. The Compnay is focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The Company operates through two segments: the Gevo, Inc. and the Gevo Development/Agri-Energy. The Gevo, Inc. segment is responsible for all research and development activities related to the production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. The Gevo Development/Agri-Energy Segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.